Who
William B. Hayes
Director
Company insider
Files Form 4 as: Director, Builders FirstSource; Director, Indaptus Therapeutics; Director, Intec Pharma; Director, Patheon; Chief Financial Officer, EVP, Labcorp Holdings.
In numbers
- Trades disclosed
- 225
- Buys
- 0
- Sells
- 32
- Bought
- $0
- Sold
- $46.4M
- Companies
- 5
- Companies where not an officer
- 4
- First trade
- 23 Feb 2006
- Last trade
- 10 Sep 2026
- Last filed
- 14 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Sep 2026filed 14 Sep 2026 | BLDR Builders FirstSourceRetail — Specialty | SEC FORM 4 Code A | —583 at $0.00 | filing |
| 10 Sep 2026filed 14 Sep 2026 | BLDR Builders FirstSourceRetail — Specialty | SEC FORM 4 Code A | —583 at $0.00 | filing |
| 1 Jun 2026filed 2 Jun 2026 | BLDR Builders FirstSourceRetail — Specialty | SEC FORM 4 Code A | $39K508 at $76.26 | filing |
| 1 Jun 2026filed 2 Jun 2026 | BLDR Builders FirstSourceRetail — Specialty | SEC FORM 4 Code A | $39K508 at $76.26 | filing |
| 14 May 2026filed 18 May 2026 | BLDR Builders FirstSourceRetail — Specialty | SEC FORM 4 Code A | —2,558 at $0.00 | filing |
| 14 May 2026filed 18 May 2026 | BLDR Builders FirstSourceRetail — Specialty | SEC FORM 4 Code A | —2,558 at $0.00 | filing |
| 1 Mar 2026filed 3 Mar 2026 | BLDR Builders FirstSourceRetail — Specialty | SEC FORM 4 Code A | $39K371 at $104.29 | filing |
| 1 Mar 2026filed 3 Mar 2026 | BLDR Builders FirstSourceRetail — Specialty | SEC FORM 4 Code A | $39K371 at $104.29 | filing |
| 1 Dec 2025filed 3 Dec 2025 | BLDR Builders FirstSourceRetail — Specialty | SEC FORM 4 Code A | $39K345 at $112.23 | filing |
| 1 Sep 2025filed 3 Sep 2025 | BLDR Builders FirstSourceRetail — Specialty | SEC FORM 4 Code A | $39K279 at $138.68 | filing |
| 10 Jun 2025filed 11 Jun 2025 | INDP Indaptus Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 1 Jun 2025filed 3 Jun 2025 | BLDR Builders FirstSourceRetail — Specialty | SEC FORM 4 Code A | $39K359 at $107.68 | filing |
| 27 May 2025filed 29 May 2025 | BLDR Builders FirstSourceRetail — Specialty | SEC FORM 4 Code A | —1,707 at $0.00 | filing |
| 10 Apr 2025filed 11 Apr 2025 | INDP Indaptus Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | $250500 at $0.50 | filing |
| 10 Apr 2025filed 11 Apr 2025 | INDP Indaptus Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | $125250 at $0.50 | filing |
| 10 Apr 2025filed 11 Apr 2025 | INDP Indaptus Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | $125250 at $0.50 | filing |
| 1 Mar 2025filed 18 Mar 2025 | BLDR Builders FirstSourceRetail — Specialty | SEC FORM 4 Code A | $37K269 at $138.99 | filing |
| 28 Feb 2025filed 4 Mar 2025 | BLDR Builders FirstSourceRetail — Specialty | SEC FORM 4 Code A | $37K269 at $138.99 | filing |
| 1 Dec 2024filed 3 Dec 2024 | BLDR Builders FirstSourceRetail — Specialty | SEC FORM 4 Code A | $37K201 at $186.47 | filing |
| 1 Sep 2024filed 4 Sep 2024 | BLDR Builders FirstSourceRetail — Specialty | SEC FORM 4 Code A | $37K215 at $174.00 | filing |
News
Labcorp To Acquire BioReference Health Assets; OPKO Shares Rise 7.35%LH · rttnews.com · 15 Oct 2026Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference HealthLH · prnewswire.com · 15 Oct 2026Labcorp (LH): Is Its Earnings Discount Worth the Growing Investment Bill?LH · insidermonkey.com · 12 Oct 2026
0 headlines in the last 90 days name William B. Hayes; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.